Agency Information Collection Activities; Proposed Collection; Comments Requested: Application for Registration; Application for Registration Renewal; Affidavit for Chain Renewal; Application for Modification of Registration for Online Pharmacies DEA Forms 224, 224a, 224b, 224c, 62530-62531 [2012-25160]
Download as PDF
<![CDATA[
62530
Federal Register / Vol. 77, No. 199 / Monday, October 15, 2012 / Notices
Avenue in Cedarburg, Wisconsin. In
return, the United States agrees not to
sue the defendant under sections 106
and 107 of CERCLA.
The publication of this notice opens
a period for public comment on the
proposed Consent Decree. Comments
should be addressed to the Assistant
Attorney General, Environment and
Natural Resources Division, and should
refer to United States v. Mercury
Marine, D.J. Ref. No. 90–11–3–10575.
All comments must be submitted no
later than thirty (30) days after the
publication date of this notice.
Comments may be submitted either by
email or by mail:
To submit
comments:
Send them to:
By email .........
pubcommentees.enrd@usdoj.gov.
Assistant Attorney General,
U.S. DOJ—ENRD, P.O.
Box 7611, Washington,
DC 20044–7611.
By mail ...........
During the public comment period,
the proposed Consent Decree may be
examined and downloaded at this
Justice Department Web site: https://
www.usdoj.gov/enrd/
Consent_Decrees.html. We will provide
a paper copy of the proposed Consent
Decree upon written request and
payment of reproduction costs. Please
mail your request and payment to:
Consent Decree Library, U.S. DOJ—
ENRD, P.O. Box 7611, Washington, DC
20044–7611.
Please enclose a check or money order
for $11.75 (25 cents per page
reproduction cost) payable to the United
States Treasury.
Maureen M. Katz,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 2012–25139 Filed 10–12–12; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
erowe on DSK2VPTVN1PROD with
[OMB Number 1117–0014]
Agency Information Collection
Activities; Proposed Collection;
Comments Requested: Application for
Registration; Application for
Registration Renewal; Affidavit for
Chain Renewal; Application for
Modification of Registration for Online
Pharmacies DEA Forms 224, 224a,
224b, 224c
ACTION:
30-Day Notice.
VerDate Mar<15>2010
15:21 Oct 12, 2012
Jkt 229001
The Department of Justice (DOJ), Drug
Enforcement Administration (DEA) will
be submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection is
published to obtain comments from the
public and affected agencies. This
proposed information collection was
previously published in the Federal
Register at 77 FR 47095, August 7, 2012,
allowing for a 60 day comment period.
The purpose of this notice is to allow
for an additional 30 days for public
comment until November 14, 2012. This
process is conducted in accordance with
5 CFR 1320.10.
If you have comments, especially on
the estimated public burden or
associated response time, suggestions,
or need a copy of the proposed
information collection instrument with
instructions or additional information,
please contact John W. Partridge, Chief,
Liaison and Policy Section, Office of
Diversion Control, Drug Enforcement
Administration, 8701 Morrissette Drive,
Springfield, VA 22152; (202) 307–7297.
Written comments concerning this
information collection should be sent to
the Office of Information and Regulatory
Affairs, Office of Management and
Budget, Attn: DOJ Desk Officer. The best
way to ensure your comments are
received is to email them to
oira_submission@omb.eop.gov or fax
them to (202) 395–7285. All comments
should reference the eight-digit OMB
number for the collection or the title of
the collection. If you have questions
concerning the collection, please
contact John W. Partridge, Chief, Liaison
and Policy Section, Office of Diversion
Control, Drug Enforcement
Administration, 8701 Morrissette Drive,
Springfield, VA 22152, (202) 307–7297,
or the DOJ Desk Officer at (202) 395–
3176.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
• Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
• Enhance the quality, utility, and
clarity of the information to be
collected; and
• Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of Information Collection
1117–0014
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection:
Application for Registration;
Application for Registration Renewal;
Affidavit for Chain Renewal;
Application for Modification of
Registration for Online Pharmacies.
(3) Agency form number, if any, and
the applicable component of the
Department sponsoring the collection:
Form number: DEA Forms 224, 224a,
224b, 224c.
Component: Office of Diversion
Control, Drug Enforcement
Administration, U.S. Department of
Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Business or other for-profit.
Other: Not-for-profit institutions;
State, local, or tribal government.
Abstract: All firms and individuals
who dispense controlled substances
must register with the DEA under the
Controlled Substances Act. Pharmacies
wishing to be online pharmacies must
apply to modify their registrations. Such
registration is mandatory under the law
and needed for control measures over
legal handlers of controlled substances
and to monitor their activities.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond:
E:\FR\FM\15OCN1.SGM
15OCN1
Federal Register / Vol. 77, No. 199 / Monday, October 15, 2012 / Notices
Number of
annual
respondents
Average time per response
62531
Total annual
hours
DEA–224 (paper) ..........................................................
DEA–224 (electronic) ...................................................
DEA–224a (paper) ........................................................
DEA–224a (electronic ...................................................
DEA–224b (chain renewal)* .........................................
DEA–224c .............................................................
5,867
79,057
66,200
323,758
32
0
0.2 hours (12 minutes) .................................................
0.13 hours (8 minutes) .................................................
0.2 hours (12 minutes) .................................................
0.07 hours (4 minutes) .................................................
5 hours ..........................................................................
0.25 hours (15 minutes) ...............................................
1,173.4
10,540.9
13,240
21,583.8
160
0
Total ..............................................................................
474,914
.......................................................................................
46,698.1
* In total, 64 chain pharmacies represent 36,660 individual pharmacy registrants. Pharmacies register for a three-year registration period. In
calendar year 2011, the year for which estimates are calculated, 32 chains registered 6,472 individual pharmacies.
(6) An estimate of the total public
burden (in hours) associated with the
collection: It is estimated that there are
46,698 annual burden hours associated
with this information collection. If
additional information is required
contact: Jerri Murray, Department
Clearance Officer, Policy and Planning
Staff, Justice Management Division,
Department of Justice, Two Constitution
Square, 145 N Street NE., Suite 2E–508,
Washington, DC 20530.
Dated: October 9, 2012.
Jerri Murray,
Department Clearance Officer, PRA, U.S.
Department of Justice.
[FR Doc. 2012–25160 Filed 10–12–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117–0047]
Agency Information Collection
Activities; Proposed Collection;
Comments Requested: Application for
Import Quota for Ephedrine,
Pseudoephedrine, and
Phenylpropanolamine; DEA Form 488
erowe on DSK2VPTVN1PROD with
ACTION:
30-Day Notice.
The Department of Justice (DOJ), Drug
Enforcement Administration (DEA) will
be submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection is
published to obtain comments from the
public and affected agencies. This
proposed information collection was
previously published in the Federal
Register 77, Number 154, page 47667,
on August 9, 2012, allowing for a 60 day
comment period.
The purpose of this notice is to allow
for an additional 30 days for public
comment until November 14, 2012. This
process is conducted in accordance with
5 CFR 1320.10.
VerDate Mar<15>2010
15:21 Oct 12, 2012
Jkt 229001
If you have comments, especially on
the estimated public burden or
associated response time, suggestions,
or need a copy of the proposed
information collection instrument with
instructions or additional information,
please contact John W. Partridge, Chief,
Liaison and Policy Section, Office of
Diversion Control, Drug Enforcement
Administration, 8701 Morrissette Drive,
Springfield, VA 22152; (202) 307–7297.
Written comments concerning this
information collection should be sent to
the Office of Information and Regulatory
Affairs, Office of Management and
Budget, Attn: DOJ Desk Officer. The best
way to ensure your comments are
received is to email them to
oira_submission@omb.eop.gov or fax
them to (202) 395–7285. All comments
should reference the eight-digit OMB
number for the collection or the title of
the collection. If you have questions
concerning the collection, please
contact John W. Partridge, Chief, Liaison
and Policy Section, Office of Diversion
Control, Drug Enforcement
Administration, 8701 Morrissette Drive,
Springfield, VA 22152, (202) 307–7297,
or the DOJ Desk Officer at (202) 395–
3897.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
• Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
• Enhance the quality, utility, and
clarity of the information to be
collected; and
• Minimize the burden of the
collection of information on those who
are to respond, including through the
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of Information Collection
1117–0047
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection:
Application for Import Quota for
Ephedrine, Pseudoephedrine, and
Phenylpropanolamine.
(3) Agency form number, if any, and
the applicable component of the
Department sponsoring the collection:
Form number: DEA form 488.
Component: Office of Diversion
Control, Drug Enforcement
Administration, Department of Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Business or other for-profit.
Other: None.
Abstract: Title 21 U.S.C. 952 and 21
CFR 1315.34 require that persons who
desire to import the List I chemicals
ephedrine, pseudoephedrine, and
phenylpropanolamine during the next
calendar year shall apply on DEA Form
488 for import quota for such List I
chemicals.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: It is estimated that 22 persons
complete 52 DEA Forms 488 annually
for this collection at 1 hour per form, for
an annual burden of 52 hours.
Respondents complete a separate DEA
Form 488 for each List I chemical for
which quota is sought.
(6) An estimate of the total public
burden (in hours) associated with the
collection: It is estimated that there are
52 annual burden hours associated with
this collection. If additional information
is required contact: Jerri Murray,
Department Clearance Officer, Policy
and Planning Staff, Justice Management
E:\FR\FM\15OCN1.SGM
15OCN1
]]>Agencies
[Federal Register Volume 77, Number 199 (Monday, October 15, 2012)]
[Notices]
[Pages 62530-62531]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-25160]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117-0014]
Agency Information Collection Activities; Proposed Collection;
Comments Requested: Application for Registration; Application for
Registration Renewal; Affidavit for Chain Renewal; Application for
Modification of Registration for Online Pharmacies DEA Forms 224, 224a,
224b, 224c
ACTION: 30-Day Notice.
-----------------------------------------------------------------------
The Department of Justice (DOJ), Drug Enforcement Administration
(DEA) will be submitting the following information collection request
to the Office of Management and Budget (OMB) for review and approval in
accordance with the Paperwork Reduction Act of 1995. The proposed
information collection is published to obtain comments from the public
and affected agencies. This proposed information collection was
previously published in the Federal Register at 77 FR 47095, August 7,
2012, allowing for a 60 day comment period.
The purpose of this notice is to allow for an additional 30 days
for public comment until November 14, 2012. This process is conducted
in accordance with 5 CFR 1320.10.
If you have comments, especially on the estimated public burden or
associated response time, suggestions, or need a copy of the proposed
information collection instrument with instructions or additional
information, please contact John W. Partridge, Chief, Liaison and
Policy Section, Office of Diversion Control, Drug Enforcement
Administration, 8701 Morrissette Drive, Springfield, VA 22152; (202)
307-7297.
Written comments concerning this information collection should be
sent to the Office of Information and Regulatory Affairs, Office of
Management and Budget, Attn: DOJ Desk Officer. The best way to ensure
your comments are received is to email them to oira_submission@omb.eop.gov or fax them to (202) 395-7285. All comments
should reference the eight-digit OMB number for the collection or the
title of the collection. If you have questions concerning the
collection, please contact John W. Partridge, Chief, Liaison and Policy
Section, Office of Diversion Control, Drug Enforcement Administration,
8701 Morrissette Drive, Springfield, VA 22152, (202) 307-7297, or the
DOJ Desk Officer at (202) 395-3176.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address one or more of the following
four points:
Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
Evaluate the accuracy of the agencies estimate of the
burden of the proposed collection of information, including the
validity of the methodology and assumptions used;
Enhance the quality, utility, and clarity of the
information to be collected; and
Minimize the burden of the collection of information on
those who are to respond, including through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses.
Overview of Information Collection 1117-0014
(1) Type of Information Collection: Extension of a currently
approved collection.
(2) Title of the Form/Collection: Application for Registration;
Application for Registration Renewal; Affidavit for Chain Renewal;
Application for Modification of Registration for Online Pharmacies.
(3) Agency form number, if any, and the applicable component of the
Department sponsoring the collection:
Form number: DEA Forms 224, 224a, 224b, 224c.
Component: Office of Diversion Control, Drug Enforcement
Administration, U.S. Department of Justice.
(4) Affected public who will be asked or required to respond, as
well as a brief abstract:
Primary: Business or other for-profit.
Other: Not-for-profit institutions; State, local, or tribal
government.
Abstract: All firms and individuals who dispense controlled
substances must register with the DEA under the Controlled Substances
Act. Pharmacies wishing to be online pharmacies must apply to modify
their registrations. Such registration is mandatory under the law and
needed for control measures over legal handlers of controlled
substances and to monitor their activities.
(5) An estimate of the total number of respondents and the amount
of time estimated for an average respondent to respond:
[[Page 62531]]
----------------------------------------------------------------------------------------------------------------
Number of
annual Average time per response Total annual
respondents hours
----------------------------------------------------------------------------------------------------------------
DEA-224 (paper)............................... 5,867 0.2 hours (12 minutes).......... 1,173.4
DEA-224 (electronic).......................... 79,057 0.13 hours (8 minutes).......... 10,540.9
DEA-224a (paper).............................. 66,200 0.2 hours (12 minutes).......... 13,240
DEA-224a (electronic.......................... 323,758 0.07 hours (4 minutes).......... 21,583.8
DEA-224b (chain renewal)*..................... 32 5 hours......................... 160
DEA-224c.................................. 0 0.25 hours (15 minutes)......... 0
-----------------------------------------------------------------
Total......................................... 474,914 ................................ 46,698.1
----------------------------------------------------------------------------------------------------------------
* In total, 64 chain pharmacies represent 36,660 individual pharmacy registrants. Pharmacies register for a
three-year registration period. In calendar year 2011, the year for which estimates are calculated, 32 chains
registered 6,472 individual pharmacies.
(6) An estimate of the total public burden (in hours) associated
with the collection: It is estimated that there are 46,698 annual
burden hours associated with this information collection. If additional
information is required contact: Jerri Murray, Department Clearance
Officer, Policy and Planning Staff, Justice Management Division,
Department of Justice, Two Constitution Square, 145 N Street NE., Suite
2E-508, Washington, DC 20530.
Dated: October 9, 2012.
Jerri Murray,
Department Clearance Officer, PRA, U.S. Department of Justice.
[FR Doc. 2012-25160 Filed 10-12-12; 8:45 am]
BILLING CODE 4410-09-P
